Latest Commercialization News

BrainChip Holdings reported a solid June quarter with $13.5 million in cash, increased customer inflows, and a strategic decision to remain listed on the ASX. The company advanced multiple commercial collaborations and expanded its intellectual property portfolio, signaling confidence in its edge AI technology roadmap.

Avecho Biotechnology has ramped up recruitment in its pivotal Phase III insomnia trial and is advancing plans for regulatory approval and commercialization of its TPM®-enhanced CBD capsule, aiming to be the first over-the-counter CBD insomnia treatment in Australia.

Scalare Partners has forged a strategic collaboration with Silicon Catalyst, a leading US semiconductor accelerator, while advancing its acquisition of Tank Stream Labs, a premier Australian tech coworking provider. These moves position Scalare at the forefront of deep tech support and infrastructure expansion.

HITIQ Ltd has launched its PROTEQT smart mouthguard for grassroots sports, secured a five-year exclusive global partnership with Shock Doctor, and raised $1.9 million to fund manufacturing and market growth.

Noble Helium advances its flagship North Rukwa helium project with a significant resource upgrade, rig exit at no cost, and new funding from key insiders, positioning for a leaner, data-driven drilling campaign.

BCAL Diagnostics has reported strong early commercial uptake of its BREASTEST plus non-invasive breast cancer diagnostic test, alongside a new partnership with Cancer Care Associates to expand market reach.

Tlou Energy progresses gas production testing at Lesedi wells while pushing forward the Kala Data Centre project, targeting operational start in Q3 2025.

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.

DroneShield Limited has reported a record-breaking second quarter with revenues surging 480% year-on-year, underpinned by a robust $176 million in committed sales and a $2.3 billion pipeline. The company is aggressively expanding manufacturing and investing in next-generation counter-drone technologies to meet soaring global demand.

Champion Iron Limited reported record quarterly iron ore concentrate sales of 3.8 million dmt and $390 million in revenue, while progressing its DRPF and Kami projects on schedule. The company also enhanced financial flexibility through a $500 million Senior Unsecured Notes refinancing.

Hawsons Iron Limited has validated a 100% dry processing circuit for its Hawsons Iron Project, securing $1.9 million in fresh capital and launching a key research collaboration with CSIRO to optimise pellet production.

Nanoveu Limited has accelerated its commercial and technological momentum with a $3.02 million capital raise, a breakthrough 33% increase in drone flight time using its edge-AI chip, and progress toward a U.S. OTCQB listing.